Scleromyxedema is a potentially serious disease that can have various systemic complications. One of the most frequent forms of central nervous system involvement is dermato-neuro syndrome. High-dose intravenous immunoglobulins are among the drug treatments that have been used for this syndrome. We describe 2 patients with scleromyxedema, one of whom developed dermato-neuro syndrome. Both patients responded well to treatment with high-dose intravenous immunoglobulins. We suggest this therapy as a suitable first-line treatment for scleromyxedema and for its neurological complications. © 2011 Elsevier España, S.L. and AEDV. All rights reserved.
|Publication status||Published - 1 Jan 2012|
- Dermato-neuro syndrome
- Intravenous immunoglobulins
- Neurological complications